greeksoup/ stock research

Omega Healthcare Investors (OHI) FY2013 results: revenue $419 million, up 19.5% on the year

Omega Healthcare Investors Inc. (OHI) reported revenue of $419 million for fiscal 2013, the year ended 31 December 2013, up 19.5% on the year before. Net income was $173 million, up 42.9%, and diluted earnings per share $1.46. The figures are the company's own, from the 10-K it filed with the SEC on 11 February 2014.

Revenue
$419 million
+19.5% on the year
FY2008FY2013
Operating margin
63.5%
61.3% a year earlier
FY2008FY2013
Net income
$173 million
+42.9% on the year
FY2008FY2013
Diluted EPS
$1.46
+30.4% on the year
FY2008FY2013

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2013FY2012FY2011On the yearLast 8 years
Revenue419350292+19.5%
Operating income266215138+23.6%
Operating margin63.5%61.3%47.2%
Interest expense10095.581.2+5.1%
Pre-tax income173n/an/a
Net income17312152.6+42.9%
Net margin41.2%34.4%18.0%
Diluted EPS$1.46$1.12$0.46+30.4%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2013FY2012FY2011On the yearLast 8 years
Operating cash flow280208170+34.4%
Capital expenditure31.329.419.6+6.5%
Free cash flow249179150+39.0%
Free cash flow margin59.4%51.0%51.4%
Cash from investing-599-391-258
Cash from financing32018481.3+74.0%
Depreciation and amortisation129113100+13.9%
Share-based compensation5.95.96.00.0%
Buybacksn/an/a2.9
Dividends paid218182162+19.7%
Dividend per share$1.86$1.69$1.55+10.1%
Diluted shares, weighted118m108m102m+9.3%
Shares outstanding at period end124m112m103m+9.9%

Balance sheet

$ millionFY2013FY2012FY2011On the yearLast 8 years
Shareholders' equity1,3001,011878+28.6%
Debt2,0241,8251,551+10.9%
Other liabilities138146127-5.5%
Total liabilities and equity3,4622,9822,557+16.1%
Cash and equivalents2.61.70.4+52.9%
Other assets3,4602,9802,557+16.1%
Total assets3,4622,9822,557+16.1%

10-K for the year ended 31 December 2013, filed 11 February 2014: the filing.